India Courts To Decide On Rabies Vaccine Claims Of Novartis, Aventis
This article was originally published in PharmAsia News
Executive Summary
Indian courts are trying to sort out claims of a shortage of rabies vaccine in the country, contradicted by Novartis India, which says there are enough vaccine doses